From a nationally representative sample of over 4.3 million people diagnosed with COVID-19 between January 2020 and February 2022, researchers identified 1,700 adults with long COVID and found that 37.3% were cancer patients. The most common cancers were skin (seen in 21.9% of the cancer patients), breast (17.7%), prostate (8.3%), lymphoma (8%) and leukemia (5.7%).
Among long COVID patients, those with cancer were older than non-cancer patients, more likely to have other medical conditions, and more likely to have been hospitalized for COVID-19. The researchers call for "further investigation to identify risk factors for long COVID in patients with cancer."
SOURCE: https://bit.ly/3NvcTie ASCO 2022, June 4, 2022.
By Reuters Staff
Posted on
Previous Article
« Breakthrough COVID-19 in cancer patients is often serious Next Article
Adding PCSK9 inhibitor to rosuvastatin after acute MI improves coronary plaque reduction »
« Breakthrough COVID-19 in cancer patients is often serious Next Article
Adding PCSK9 inhibitor to rosuvastatin after acute MI improves coronary plaque reduction »
Related Articles
May 21, 2019
Adjuvant Her2-targeted therapy
February 21, 2022
For sentinel node-positive melanoma treatment, location matters
September 30, 2020
Atezolizumab results show benefit for selected NSCLC patients
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy